Study on Patient Experiences of Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery

What this Trial Is About

This research aims to evaluate genital sensitivity and sexual function following genital gender affirming surgery in people with gender dysphoria. Gender dysphoria is a distress caused by a difference between assigned biological sex and experienced gender identity. Treatment often includes psychological support, hormone therapy, and genital surgery to align physical traits with gender identity. Despite extensive study of urinary function after surgery, the impact on sexual function and sensory recovery remains less understood. The study involves genital sensation testing using the Semmes-Weinstein monofilament test and a series of questionnaires assessing sexual function, urination, quality of life, and patient satisfaction. Patients who undergo genital gender affirming surgeries such as vulvoplasty, vaginoplasty, metoidioplasty, or phalloplasty will be observed. Follow-up assessments are scheduled at 3, 6, 9, 12, 15, 18, 21, and 24 months after surgery to monitor changes in sensitivity and functional outcomes. Participants will complete baseline and follow-up questionnaires and clinical tests, including uroflowmetry and patient self-assessments. Researchers will track surgical complications within 90 days post-operation and collect data on voiding function, urinary continence, satisfaction with life, and quality of life. The primary outcome is the change in genital sensitivity over 24 months. The study spans up to two years of follow-up to comprehensively understand recovery and patient satisfaction after surgery.

Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery